Perspective Therapeutics (CATX) Receivables - Other (2011 - 2025)

Perspective Therapeutics has disclosed Receivables - Other across 15 years of filings, most recently posting $10000.0 for Q4 2025.

• Receivables - Other for Q4 2025 came in at $10000.0, down 97.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $10000.0 (down 97.95% YoY), and the FY2025 annual result was $10000.0, down 97.95% from the prior year.
• Receivables - Other came in at $10000.0 for Q4 2025 at Perspective Therapeutics, down from $487000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $487000.0 in Q4 2024 to a low of $2000.0 in Q4 2022.
• The 5-year median for Receivables - Other is $13500.0 (2022), against an average of $93000.0.
• Across the five-year window, Receivables - Other jumped 4770.0% in 2024 and plunged 97.95% in 2025, its largest moves.
• Perspective Therapeutics' Receivables - Other stood at $32000.0 in 2021, then plunged by 93.75% to $2000.0 in 2022, then jumped by 400.0% to $10000.0 in 2023, then surged by 4770.0% to $487000.0 in 2024, then slumped by 97.95% to $10000.0 in 2025.
• The last three Receivables - Other figures came in at $10000.0 (Q4 2025), $487000.0 (Q4 2024), and $10000.0 (Q4 2023), per Business Quant data.